Pauline Zamprogno Email

Products & Clients Manager . AlveoliX AG

Current Roles

Employees:
10
Revenue:
$2.5M
About
Our Vision We aim at changing the way drug development research is done today by providing in-vitro models that reproduce the in-vivo environment in an unprecedented way. These in-vitro models, called organ-on-chips, will make it possible to better predict drugs' responses in humans than standard in-vitro and in-vivo models and as a consequence to importantly reduce animal testing. Our Mission AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
AlveoliX AG Address
Freiburgstrasse 3
Bern, null
AlveoliX AG Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.